Lupin Q1 PAT up 33.5% to Rs 280 cr, stock up 2.5%
Drug producer Lupin reported strong numbers on all parameters in the quarter ended June 2012. Profit after tax grew by 33.5% year-on-year 80.2% quarter-on-quarter to Rs 280.4 crore in the first quarter of financial year 2012-13.
July 24, 2012 / 18:12 IST
Drug producer Lupin reported strong numbers on all parameters in the quarter ended June 2012. Profit after tax grew by 33.5% year-on-year 80.2% quarter-on-quarter to Rs 280.4 crore in the first quarter of financial year 2012-13.
Company benefitted from currency depreciation, hence that added 7% to the topline and resulted in a 44% growth; without currency depreciation, revenues grew by 37%. Revenues went up by 44% YoY and 17% QoQ to Rs 2,253 crore and earnings before interest, tax, depreciation and amortisation (EBITDA) increased 55.6% YoY and 23% QoQ to Rs 457.6 crore during the same quarter.Operating profit margin improved 150 basis points year-on-year and 90 basis points quarter-on-quarter to 20.3% in the April-June quarter of 2012.Bottomline in the quarter was not comparable with previous quarter as the company's income included forex and litigation costs in March quarter of 2012.The stock touched a 52-week high of Rs 584.55 today. At 15:21 hours IST, the share was trading at Rs 584.55, up 2.50% amid hefty volumes. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
